Effects of histamine on coronary hemodynamics in humans: Role of H1and H2receptors  by Vigorito, Carlo et al.
lACC Vol. 10, No 6
December 1987:1207-13
1207
Effects of Histamine on Coronary Hemodynamics in Humans: Role of
HI and 8 2 Receptors
CARLO VIGORITO, MD, ARTURO GIORDANO, MD, LORENZO DE CAPRIO, MD,
DINO FRANCO VITALE, MD, NICOLA MAUREA, MD, PAOLO SILVESTRI, MD,
BERNARDINO TUCCILLO, MD, NICOLA FERRARA, MD, GIANNI MARONE, MD*,
FRANCO RENGO, MD
Naples, Italy
To evaluate whether histamine exerts a direct effect on
coronary hemodynamics in humans, and to investigate
the role played by H. and H2 receptors in this response,
intracoronary saline solution or histamine (4 p,g) was
administered in 10 patients with normal coronary ar-
teries during diagnostic cardiac catheterization. Hista-
mine injection was repeated after intravenous cimetidine
(400 mg) and diphenhydramine (10 mg). The electro-
cardiogram, arterial pressure and thermodilution coro-
nary blood flowwere continuously monitored during and
for 40 seconds after each injection.
Immediately after histamine injection there was a
significant increase in coronary blood flow (65 ± 6%)
and a decrease in coronary vascular resistance ( - 40 ±
3%) (both p < 0.001), with minor changes in the RR
interval and the mean arterial pressure. H2 receptor
blockade with cimetidine did not affect these changes,
while HI receptor blockade with diphenhydramine sig-
Exogenous (1,2) and endogenous (3) histamine produces
significant cardiovascular effects in humans that are me-
diated by specific HI and Hz cardiovascular receptors (4).
Although histamine is known to induce coronary vasodi-
lation or vasoconstriction in animals, depending on species,
dose and study design (5-9), the direct effects exerted by
histamine on the human coronary circulation are less under-
stood, Histamine is contained in large amounts in the heart
(10) and can be released by immunologic (3, II) and non-
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nificantly reduced the histamine-induced increase in
coronary blood flow and the decrease in coronary vas-
cular resistance (26 ± 6%, P < 0.005 and -18 ± 5%,
P < 0.001, respectively). Twenty to 30 seconds after
histamine injection, a significant decrease in mean ar-
terial pressure (-17 ± 2%, P < 0.001) and in the RR
interval (- 4 ± 1%, P < 0.01) was observed. These
changes persisted after H2 receptor blockade with d-
metidine, but were completely abolished after H. recep-
tor blockade with diphenhydramine. In each case coro-
nary and systemic hemodynamics returned to normal
within 40 seconds of the injection.
Therefore, in patients with normal coronary arteries,
histamine induces a direct dilation of the small resistance
coronary arteries, regardless of myocardial metabolic
requirement, that is predominantly, but not completely,
mediated by H. receptors.
(J Am Coli CardioI1987jlO:1207-13)
immunologic stimuli (12,13). In humans, histamine is pres-
ent in coronary artery walls, particularly in patients with
coronary artery disease (14) and in those with variant angina
(15). In vitro studies on human large coronary arteries have
shown that histamine induces a coronary vasoconstrictor
effect that is enhanced by the atherosclerotic process (14,16).
This vasoconstriction is due to activation of HI receptors;
Hz receptors subserve vasodilation (17), However, these
results can hardly be extrapolated to the in vivo coronary
circulation and to subjects with normal coronary arteries.
In fact, a recent study from our institution (18) has shown
that H I receptors mediate peripheral coronary vasodilation
in patients without coronary artery disease but may induce
large epicardial coronary artery constriction in patients with
vasospastic angina, with or without organic narrowing.
However, the effects of histamine on the cardiovascular
system in vivo are in part directly mediated by specific
cardiovascular histamine receptors and in part by histamine-
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induced changes in factors that affect myocardial metabolic
requirement, or by reflex increases in sympathoadrenergic
activity and catecholamine release (2). It is therefore dif-
ficult to evaluate the direct effects exerted by histamine on
the human coronary circulation in vivo.
The aim of the present study was twofold: I) to evaluate
the presence of a direct effect of histamine on the human
coronary circulation by direct intracoronary histamine in-
jection in a group of patients with angiographically normal
coronary arteries; and 2) to assess the role of HI and H2
receptors in this response by selective HI and H2 blockade.
Methods
Study patients. The study group was composed of 10
patients whose clinical and angiographic data are shown in
Table I. All patients had normal coronary arteries, and no
patient had a history of allergy, pheochromocytoma, peptic
ulcer or chronic obstructive lung disease. Patients with car-
diomyopathy or ventricular arrhythmia were also excluded.
Patients were studied in the morning after an overnight fast
and without premedication. All drugs, except sublingual
nitrates when required, were discontinued for at least 5 half-
lives. However, no patient consumed nitrates within 24
hours before the morning of the study. The study protocol
was approved by the Ethics Committee of our institution
and informed consent was obtained from each patient.
Study protocol. The study was initiated after completion
of diagnostic coronary arteriography, performed by the Sones
technique. Thirty minutes was allowed for a return to base-
line hemodynamic conditions. Previous observations (7) have
shown that contrast medium-induced changes in systemic
and coronary hemodynamics are short-lasting.
During this interval, a 7F Wilton Webster catheter for
the measurement of coronary blood flow by thermodilution
(19) was advanced into the coronary sinus. Details of the
technique utilized to maintain a correct position of the cath-
eter throughout the study have been published elsewhere
(18). An 8F Hemaquet sleeve was introduced into the bra-
chial artery, and its lateral extension was connected to a
Statham P23 Id transducer to allow continuous monitoring
of arterial pressure. A 7.5F Sones catheter was advanced
through the sleeve to the left coronary ostium and particular
care was taken to ensure that it was in a stable position in
the ostium.
Injection. of histamine into the left coronary artery.
After positioning the catheters, we started measuring base-
line coronary blood flow and arterial pressure under con-
tinuous electrocardiographic (ECG) monitoring. Coronary
blood flow was measured according to the technique de-
scribed by Ganz et al. (19), by injecting saline solution into
the distal coronary sinus through the thermodilution catheter
at a constant rate of 60 mllmin with a Sage model 355
infusion pump. Thermistor signals, together with arterial
pressure and ECG were recorded on an OTE multichannel
polygraph at a paper speed of 100 mm/s. After 20 seconds
of equilibration, while continuing coronary blood flow and
arterial pressure recording, we started a 10 second injection
of 5 ml of physiologic saline solution or 4 JLg of histamine
diluted in 5 ml of saline solution into the left coronary artery
(Fig. 1). Event markers were recorded on paper in order to
time exactly the point of onset and termination of intracor-
onary injection. Coronary blood flow, arterial pressure and
ECG were continuously monitored during the 10 second
injection and for 40 seconds after the end of the intracor-
onary injection.
Each patient received four separate intracoronary injec-
tions in the following order (Fig. 2): I) intracoronary saline
solution; 2) intracoronary histamine; 3) intracoronary his-
tamine after H2 receptor blockade with cimetidine; 4) intra-
coronary histamine after HI receptor blockade with diphen-
hydramine. After each intracoronary injection, 5 minutes
Table 1. Clinical and Angiographic Features of the 10 Study Patients With Normal Coronary Arteries
Clinical
Left Ventriculography
Patient Age (yr) & Sex Presentation Risk Factor TET ET EOV(ml) ESV(ml) EF(%)
I 37F Atypical angina Smoking +1- 83 10 88
2 55F Atypical angina HBP NO 90 21 76
3 49M Angina on effort Smoking +1- 158 58 63
4 37F Atypical angina NO NO
5 53F Atypical angina + NO 100 22 78
6 29F Secundum ASO NO ND 90 35 61
7 48F Angina on effort HBP 83 10 88
8 37F Atypical angina Smoking NO 125 46 63
9 44F Mild MR + MS HBP NO NO 205 97 52
10 23M Atypical angina Familial history NO 138 53 61
Mean ± SO 41 ± 10 119 ± 42 39 ± 28 70 ± 13
ASO = atrial septal defect; EOV = end-diastolic volume; EF = ejection fraction; ESV = end-systolic volume; ET = ergonovine test; HBP =
high blood pressure; MR + MS = mitral regurgitation + stenosis; NO = not done; TET = treadmill exercise test; + = positive; - = negative;
+1- = borderline.
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CBF-AP-ECG
Histamine or saline
intracoronary injection
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Figure 1. Schematic representation of the protocol used for each
intracoronary injectionof histamineor saline. AP = artenal pres-
sure; B = baseline; CBP = coronary blood flow; ECG = elec-
trocardiogram; EP = early period; LP = late period; R = re-
covery. See text for explanation.
were allowed for hemodynamic return to baseline condi-
tions. Cimetidine was given as a 400 mg intravenous bolus
injection over 5 minutes and the second histamine injection
was performed 15 minutes later. Diphenhydramine was giv.en
as a 10 mg intravenous bolus over 5 minutes and the third
histamine injection was performed 10 minutes later. The
intracoronary position of the tip of the Sones catheter was
confirmed in all cases by the typical ST-T segment changes
during intracoronary injection and by fluoroscopy at the end
of injection.
In order to establish the consistency of the coronary
hemodynamic response to repeated intracoronary hista-
mine. we also studied, as a separate protocol, three addi-
tional patients with clinical and angiographic characteristics
similar to those of the 10 patients reported in Table I. The
general protocol followed in these three patients was the
same as that shown in Figures 1 and 2, but cimetidine and
diphenhydramine were not administered.
There were no subjective complaints or complications
with intracoronary administration of histamine. In partic-
ular, no pulsating headache or cutaneous flush was ob-
served, nor were arrhythmias or conduction disturbances of
any type recorded.
Measurements. RR interval (from the ECG recordings),
mean arterial pressure (as diastolic plus one third of pulse
pressure), coronary blood flow and coronary vascular re-
sistance (derived as the ratio of mean arterial pressure to
coronary blood flow) were measured just before the onset
of each intracoronary injection, immediately after the in-
jection (early period) and 30 seconds (late period) and 50
Figure 2. Schematic representation of the se9ue~ce of intracor-
onary injectionof histamine(H) or saline solution In each patient.
CIM = cimetidine; mPH = diphenhydramine.
SALINE t:I t! t:I
• • • •Time I I I I I I I(min) 0 lOU2O 30 Lt 50 60
elM DIPH
seconds (recovery) after the onset of the intracoronary in-
jection (Fig. I). RR intervals and the mean arterial pressure
were measured as the average of 5 consecutive beats.
Coronary bloodfiow was calculated asfollows: coronary
blood flow = 60 x 1.08 x (Tb-Ti/Tb-Tm) - I, where
Tb, Ti and Tm = temperature of blood, injectate and blood-
injectate mixture, respectively; 60 = coronary sinus injec-
tate flow rate, and 1.08 = a constant accounting for the
specific heat and density of blood and saline solution (19).
In seven patients we also measured from paper record-
ings the pre-ejection period/left ventricular ejection time
ratio (PEP/LVET) and the relation between the electrical
and mechanical systole, expressed as the QT/QD ratio, be-
fore and after the first intracoronary histamine injection, in
the absence of H I and Hz receptor blockade (QD = interval
from Q wave to onset of diastole). These time intervals were
measured at baseline, as the average value of the 5 beats
immediately preceding the intracoronary histamine injec-
tion, and in the early period after histamine injection, as
the average value of the 5 beats immediately following the
end of the injection.
Left ventricular ejection time was measured from the
onset of the upstroke of systolic arterial pressure to the
dicrotic notch. Pre-ejection period was measured from the
Q wave of the ECG to the onset of the upstroke of systolic
arterial pressure, minus the delay in pulse transmission time
from aortic root to brachial artery, that was measured in
each of these seven patients at the beginning of the study.
The QT interval was measured from the Q wave of the ECG
to the termination of the T wave; in order to minimize errors
in evaluating the termination of the T wave, at the beginning
of the study the ECG lead with the sharpest delineation of
this point was selected. The QD interval was measured from
the Q wave of the ECG to the dicrotic notch of arterial
pressure, minus the delay in pulse transmission time as
previously evaluated.
Statistics. Statistical analysis was performed by Stu-
dent's t test for paired samples. Results were expressed as
percent change from baseline of all hemodynamic variables
measured. Values were expressed as mean ± standard error
of the mean (SEM). A P value of <0.05 was considered
statistically significant.
Results
Figures 3 and 4 show the percent changes in RR interval,
mean arterial pressure, coronary blood flow and coronary
vascular resistance after intracoronary administration of sa-
line solution, and intracoronary administration of histamine
alone and after intravenous cimetidine and after intravenous
diphenhydramine at the various time intervals of the study .
Changes in RR interval and mean arterial pressure
(Fig. 3). No significant percent change in any hemodynamic
variable was observed after intracoronary saline. The RR
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Figure 3. Percent changes in the RR interval and in the mean
arterial pressure (MAP) after intracoronary injection of saline so-
lution (0---0), histamine (.-.), histamine after cimetidine
(e-·-e) and histamine after cimetidine + diphenhydramine
(0···0). Otherabbreviations as in Figure 1. Values are expressed
as mean ± SEM. *p < 0.05, tp < 0.02, +p < 0.01, §p < 0.001
(vs. saline).
Figure 4. Percent changes in coronary blood flow (CBF) and
coronary vascular resistance (CVR) after intracoronary injection
of saline solution (0---0), histamine (.-.), histamine after
cimetidine (e-·-e) and histamine after cimetidine + diphen-
hydramine (0..·0). Other abbreviations as in Figure I. *p <
0.02, tp < 0.01, +p < 0.005, §p < 0.001 (vs. saline solution),
**p < 0.005 and p < 0.001 (vs. histamine and histamine after
cimetidine, respectively).
interval did not significantly change in the early period of
any injection, but it decreased 4 ± I% in the late period
of histamine injection before blockade (p < 0.01 versus
saline solution), and 5 ± 1% in the late period of histamine
injection after cimetidine (p < 0.01 versus saline solution).
The RR interval did not change significantly with intracor-
onary histamine after diphenhydramine, either in the late
period or in the recovery phase. The mean arterial pressure
(Fig. 3) decreased by 3 ± I% in the early period Of his-
tamine injection without blockade (p < 0.05 versus saline
solution) and by 4 ± 1% (p < 0.02 versus saline solution)
in the early period of histamine injection after cimetidine,
in both instances showing a marked fall in the late period
(respectively by 17 ± 2% and 16 ± 3%,p<0.001 versus
saline solution), with a return to baseline in the recovery
phase. No significant change in the mean arterial pressure
was observed with histamine injection after diphenhydra-
mine.
Changes in coronary hemodynamics (Fig. 4). Coro-
nary blood flow increased 65 ± 6% in the early period of
histamine injection without blockade and by 65 ± II %
after cimetidine (both p < 0.001 versus saline solution),
with a return toward baseline in the late period and recovery
phase of these two injections. With histamine after diphen-
hydramine, we observed a moderate but still significant
percent increase in coronary blood flow in the early period
(26 ± 6%, P < 0.005 versus saline solution) that was,
however, lower than the increase observed with histamine
before blockade and with histamine after cimetidine (p <
0.005 versus the two previous injections). Coronary blood
flow returned immediately to baseline in the late period and
in the recovery phase.
Coronary vascular resistance decreased by 40 ± 3% in
the early period of histamine injection before blockade and
by 41 ± 4% after cimetidine (both p < 0.001 versus saline
solution), in both instances remaining significantly lower
than baseline in the late period and returning to baseline in
the recovery phase. With histamine injection after diphen-
hydramine, we observed a slight but significant decrease of
coronary vascular resistance in the early period (18 ± 5%,
P < 0.005 versus saline solution) that was, however, lower
than the decrease observed with the histamine injection be-
fore blockade and after cimetidine (p < 0.001). Coronary
vascular resistance returned immediately to baseline in the
late period and recovery phases of this injection.
Figure 5 shows the mean percent increase in coronary
blood flow in the early period after intracoronary histamine
injection in three patients who received three consecutive
intracoronary histamine injections without H2 or HI receptor
blockade. There was no statistically significant difference
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B = baseline; H = immediately after intracoronary histamine injection ;
NS = not significant; PEP/LVET = pre-ejection period/left ventricular
ejection time ratio; QT/QD = ratio of electrical to mechanical systole.
The present study shows that in patient s with normal
coronary arteries and without vasospastic angina . histamine
induces a direct coronary vasodilator effect that is indepen -
dent of changes in the determinants of myocardial oxygen
consumption . In fact , without HI and H2 blockade, coronary
vascular resistance decreased and coronary blood flow in-
creased immediately after intracoronary histamine injection
(early period phase) , when no change in the RR interval
(and thus in heart rate) and no increa se or even a small
reduction in arterial pressure had occurred. Because heart
rate and arterial pressure are two of the major determinants
of myocardial oxygen consumption (20), these data indicate
a histamine induced dilation of small coronary resistance
vessels independent of enhanced myocardial metabolic re-
quirements.
It is unlikely that other factors that affect myocardial
oxygen consumption, such as catecholamine release or
change s in left ventricular contractility or volume, may have
played a role in this early coronary vasodilation . Although
histamine can directl y enhance left ventricular contractility
through H2 receptors (2 1) or indirectly through a histamine-
induced catecholamine release and stimulation of beta, ad-
renergic receptors (22), this is unlikel y to have occurred
because the PEP/LVET ratio , an index well reflecting di-
rectional variations in left ventricular inotropism (23) . did
not significantly change in the early phase after intracoro-
nary histamine . In addition , H2 receptor blockade by ci-
metidine did not modify the coronary hemodynamic re-
sponse to intracoronary histamine (Fig. 4) , nor did we observe
any change in QTIQD, a ratio well reflecting autonomic
tone variations at the myocardial level and thus sensitive to
sympathetic stimulation of the left ventricle (24). Cate -
cholamine-induced pharmacologic coronary vasodilation is
also unlikely because vasocon strictor alpha, adrenergic re-
ceptors are predominant in coronary artery smooth muscle
(25). Therefore, the coronary vasodilation observed im-
mediately after intracoronary histamine is likely due to a
direct vasodilator effect of histamine on small coronary re-
sistance vessels.
Receptor mechanism underlying the d irect coronary
hemodynamic effects of histamine. Studies ( 17) on human
coronary arteries in vitro have shown that histamine induces
Hj-mediated constriction and Hy-mediared vasodilation of
large epicardial coronary arteries. However, these experi-
mental studies cannot be extrapol ated to humans in vivo
because they are limited to the effects of histamine on large
capacitance coronary arteries and do not take into account
the multiple factor s capable of affecting coronary vaso-
motion in vivo. In this respect , recent in vivo studies ( 18, 26)
have suggested that activation of H I receptors might provoke
epicardial coronary constriction or spasm in a subset of
patient s with variant angina with or without atherosclerotic
narrowing, while inducing dilation of resistance coronary
vessels in patients with normal coronary arteries (18). How-
1 2 3
HISTAMINE INJECTION
o
20
PEP/LVET QT/QD
Patient B H B H
1 0.406 0.398 0.90 0.87
2 0.374 0.308 0.89 0.91
3 0.302 0.256 0.94 0.86
4 0.306 0.290 1.03 0.98
5 0.302 0.259 1.06 1.06
6 0.210 0.203 1.00 1.05
7 0.188 0.210 1.00 0.98
Mean ± SEM 0.298 0.274 0.97 0.96
0.07 0.06 0.06 0.08
NS NS
Discussion
Direct coronary hemo dynamic effects of histamine.
Earlier observations in experimental animal s (5- 9) and in
vitro findings obtained on human coronary arteries (17) showed
a direct effect of histamine on coronary vasomotion. We
have demonstrated that intravenous histamine produces H )-
mediated coronary vasodilation that can be attributed, at
least in part, to reflex cardiovascular changes secondary to
histamine-induced hypotension (18).
LL 60
CD
u
:; 40
Table 2. Changes in Individual and Mean ( ± SEM) Values of
PEP/LVET and of QT/QD Ratio With Intracoronary
Histamine Injection
among the three injections in the percent increase in coro-
nary blood flow immediately after intracoronary histamine .
Changes in PEP/LVET and QT/QD ratio (Table 2).
No statistically significant difference was found between
baseline and postinjection values of the PEP/LVET and
QTIQD ratio s before and immediately after the first intra-
coronary histamine injection.
Figure 5. Mean percent increase in coronary blood flow (CBF)
in the early period immediately after intracoronary histamine in-
jection in three patients who received three consecutive intracor-
onary histamine injections without H2 and H) receptor blockade.
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ever, these studies were based on systemic histamine admin-
istration and, therefore, could not separate the systemic from
the coronary hemodynamic effects of histamine.
In the present study, the effects of repeated intracoronary
histamine injections after selective histamine receptor block-
ade suggest that the direct coronary vasodilator effect of
histamine is mediated by HI receptor activation because
diphenhydramine, but not cimetidine, significantly de-
creased the histamine-induced decrease in coronary vascular
resistance. The latter can hardly be attributed to acute de-
sensitization to the coronary vasodilator effect of histamine
because three consecutive intracoronary histamine injections
without Hz or HI receptor blockade in three patients produced
the same consistent coronary vasodilator effect (Fig. 5).
These data confirm and extend to humans the finding that
H I receptor activation produces peripheral vasodilator ef-
fects in several vascular regions, including the coronary
region (6,8,9,27,28), and suggest that, in contrast to what
has been reported for other vascular districts (29), Hz re-
ceptors do not playa major role in the peripheral coronary
vasodilation induced by histamine.
The slight but significant peripheral coronary vasodila-
tion persisting even after combined Hz and HI blockade
suggests that part of the direct vasodilator effect of histamine
is independent of the known H I and Hz receptor mecha-
nisms. It is unlikely that this persistent vasodilation is me-
diated by the activation of the H3 receptor recently described
in the brain (30). An incomplete HI and Hz receptor block-
ade, allowing a persistent coronary dilation even after the
third histamine injection, can be ruled out by the prevention
of heart rate and arterial pressure changes with histamine
injection after combined cimetidine and diphenhydramine
pretreatment. However, our data do not allow us to hy-
pothesize any mechanism or mechanisms responsible for
the coronary dilation persisting after combined HI and Hz
receptor blockade.
Systemic hemodynamic effects of intracoronary his-
tamine. Histamine injected by the intracoronary route
produces its typical effects, represented by tachycardia and
hypotension (1,2), on systemic hemodynamics. These ef-
fects are mediated in large part by H I receptors because
they are not modified by cimetidine, but are prevented by
diphenhydramine. Although a previous study (I) showed
that systemic hypotension after histamine administration is
mediated by both HI and Hz receptors, HI receptors are
predominantly involved in the systemic hypotensive re-
sponse to a bolus injection of small doses of histamine as
used in our study (31).
The slight decrease in arterial pressure in the early phase
of intracoronary injection of preblockade histamine and
postcimetidine histamine might be due to a negative ino-
tropic effect of histamine mediated by HI receptors (32)
because it persisted after cimetidine but was abolished by
diphenhydramine. However, we cannot discount that a role
might have been played by a small amount of histamine that
escaped the intracoronary route and reached the peripheral
circulation.
The tachycardic response to histamine can be attributed
to a direct histamine effect on the sinus node through Hz
receptors (4) or to a reflex sympathoadrenergic activation
(2). The present study supports the latter hypothesis because
no change in the RR interval was observed in the early
period after intracoronary histamine, when coronary hemo-
dynamic changes had already occurred, in those patients
with a sinus node artery arising from the circumflex coronary
artery. In all patients the reduction in the RR interval par-
alleled the fall in systemic arterial pressure, thus suggesting
a reflex sympathoadrenergic activation.
Possible limitations of the study. The conclusions reached
in our study, that histamine mediates small vessel coronary
vasodilation through HI receptors in patients with normal
coronary arteries and without evidence of vasospastic an-
gina, should not be extrapolated to patients with coronary
artery disease or vasospastic angina. In fact, in a percentage
of these patients, HI receptor activation may mediate vaso-
constriction or spasm of large epicardial coronary arteries
(18,26). In addition, we cannot exclude the possibility that
the effects of endogenous histamine released locally within
the vessel wall (11,13,15) in anaphylactic reactions might
differ quantitatively or qualitatively from those outlined in
our study.
Finally, because we did not investigate the change in
diameter of proximal coronary arteries, we cannot rule out
that, as shown in in vitro studies (16,17), H I receptor stim-
ulation may induce vasoconstriction of large epicardial coro-
nary arteries. However, it is unlikely that mild proximal
coronary constriction, should it have occurred, might have
influenced the coronary hemodynamic changes found in our
patients, because in the absence of coronary artery disease
or vasospastic angina, coronary vascular resistance is greatly
influenced by the tone of small coronary arterioles (7).
Clinical implications. Our results might have relevance
for a better understanding of coronary hemodynamic changes
in patients without coronary artery disease or vasospastic
angina during systemic histamine release in the course of
anaphylactic or anaphylactoid reactions (3,12). These re-
actions are occasionally associated with ECG signs of myo-
cardial ischemia or with myocardial infarction (33-35). Our
findings suggest that these events are not secondary to a
direct coronary effect of histamine, even in patients taking
Hz receptor blocking drugs, because in these patients HI
receptor stimulation is more likely to induce peripheral coro-
nary vasodilation. Although we cannot rule out a proximal
coronary vasoconstrictor effect of HI receptor stimulation,
this cannot be to such an extent as to counterbalance the
peripheral coronary vasodilation. It is more likely that isch-
emic events during anaphylactic reactions in patients with
normal coronary arteries are secondary to the systemic ef-
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fects of histamine or to the release of other chemical me-
diators of anaphylaxi s, such as leukotriene s or platelet-ac-
tivating factor , which are able to produce a marked
derangement of cardio vascular function (36, 37).
We are indebted to our catheteriza tion technician , Gae tano Mancini. for
his invaluable help in the performan ce of this study .
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